Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

New model created for CFTR gene nonsense mutation W1282X cystic fibrosis

Oct. 19, 2020

Avalyn advances phase I/II study of AP-101 in IPF

Oct. 19, 2020

Chitinase-3-like protein 1 identified as cystic fibrosis therapeutic target

Oct. 16, 2020

Investigator-initiated study of IONIS-PKK-LRx in patients with COVID-19 begins

Oct. 16, 2020

Mucolytic agent MUC-031 has beneficial effects in cystic fibrosis model

Oct. 16, 2020

FDA grants expanded access to ExoFlo for COVID-19-associated ARDS

Oct. 14, 2020

Targeting Ire1-alpha may reduce cystic fibrosis airway inflammation

Oct. 14, 2020

Gossamer Bio presents topline phase II data for GB-001

Oct. 14, 2020

Pivotal trial of Dupixent in children with moderate to severe asthma meets primary endpoint

Oct. 13, 2020

Sorrento licenses PSC's mesenchymal stem cells for COVID-19-associated ARDS

Oct. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...